Healthcare - Biotechnology - NASDAQ - US
$ 50.22
-8.19 %
$ 5.93 B
Market Cap
-9.33
P/E
Price Target
Average
84.19%
Revenue Forecast
Estimate
277.23%
EBIT
Estimate
--32.40%
Net Income
Estimate
26.43%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Cytokinetics, Incorporated
Wall Street analysts predict an average 1-year price target for CYTK of $92.5 , with forecasts ranging from a low of $60 to a high of $120 .
CYTK Lowest Price Target
Wall Street Target
60 USD
19.47%
CYTK Average Price Target
Wall Street Target
92.5 USD
84.19%
CYTK Highest Price Target
Wall Street Target
120 USD
138.95%
REVENUE FORECAST
Revenue Forecast Chart CYTK
EBIT FORECAST
EBIT Forecast Chart CYTK
NET INCOME FORECAST
Net Income Chart CYTK